NewslettersEndothelial Cell NewsHematopoiesis NewsProstate Cell NewsPulmonary Cell News Merck Announces Phase III Trial Initiations for Four Investigational Candidates from its Promising Hematology and Oncology Pipeline By Laurisa Dohm - January 12, 2024 0 Merck announced the initiation of pivotal Phase III trials for four of its investigational candidates from its diverse pipeline in hematologic malignancies and solid tumors. [Merck] Press Release